Expression and mechanism of PinX1 and telomerase activity in the carcinogenesis of esophageal epithelial cells

Oncology Reports

Volumn 30, Issue 4, 2013, Pages 1823-1831

  Zuo, Jing ^a   Wang, Da Hu ^a   Zhang, Yu Jun ^b   Liu, Liang ^a   Liu, Feng Ling ^a   Liu, Wei ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b Department of Pathology   (China)

Author keywords

Apoptosis; Esophageal carcinoma; Human telomerase reverse transcriptase; Pin2 TRF1 interacting protein X1; Telomerase activity

Indexed keywords

DNA; PROTEIN PINX1; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL PROLIFERATION; CHINA; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; EPITHELIUM CELL; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CARCINOMA; ESOPHAGUS DYSPLASIA; ESOPHAGUS MUCOSA; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SILVER STAINING; TELOMERE SHORTENING; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; UPREGULATION;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; G1 PHASE CELL CYCLE CHECKPOINTS; HUMANS; MALE; MIDDLE AGED; RNA, MESSENGER; TELOMERASE; TELOMERE; TELOMERE HOMEOSTASIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 84882675541     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2649     Document Type: Article

References (36)

1. Risques RA, Vaughan TL, Li X, et al: Leukocyte telomere length predicts cancer risk in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 16: 2649-2655, 2007.
2. Xing J, Ajani JA, Chen M, et al: Constitutive short telomere length of chromosome 17p and 12q but not 11q and 2p is associated with an increased risk for esophageal cancer. Cancer Prev Res (Phila) 2: 459-465, 2009.
3. Cohen SB, Graham ME, Lovrecz GO, et al: Protein composition of catalytically active human telomerase from immortal cells. Science 315: 1850-1853, 2007.
4. Pao CC, Tseng CJ, Lin CY, et al: Differential expression of telomerase activity in human cervical cancer and cervical intraepithelial neoplasia lesions. J Clin Oncol 15: 1932-1937, 1997.
5. Anderson S, Shera K, Ihle J, et al: Telomerase activation in cervical cancer. Am J Pathol 151: 25-31, 1997.
6. Heselmeyer-Haddad K, Janz V, Castle PE, et al: Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia. Am J Pathol 163: 1405-1416, 2003.
7. Heselmeyer-Haddad K, Sommerfeld K, White NM, et al: Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer. Am J Pathol 166: 1229-1238, 2005.
8. Andersson S, Wallin KL, Hellström AC, et al: Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas. Br J Cancer 95: 331-338, 2006.
9. Hopman A, Theelen W, Hommelberg P, et al: Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer. J Pathol 210: 412-419, 2006.
10. Sokolova I, Algeciras-Schimnich A, Song M, et al: Chromosomal biomarkers for detection of human papillomavirus associated genomic instability in epithelial cells of cervical cytology specimens. J Mol Diagn 9: 604-611, 2007.
11. Caraway NP, Khanna A, Dawlett M, et al: Gain of the 3q26 region in cervicovaginal liquid-based pap preparations is associated with squamous intraepithelial lesions and squamous cell carcinoma. Gynecol Oncol 110: 37-42, 2008.
12. Hashimoto Y, Murakami Y, Uemura K, et al: Detection of human telomerase reverse transcriptase (hTERT) expression in tissue and pancreatic juice from pancreatic cancer. Surgery 143: 113-125, 2008.
13. Saha B, Chaiwun B, Tsao-Wei DD, et al: Telomerase and markers of cellular proliferation are associated with the progression of cervical intraepithelial neoplasia lesions. Int J Gynecol Pathol 26: 214-222, 2007.
14. Branca M, Giorgi C, Ciotti M, et al: Upregulation of telomerase (hTERT) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high-risk human papillomavirus, virus persistence, or disease outcome in cervical cancer. Diagn Cytopathol 34: 739-748, 2006.
15. Kondo T, Oue N, Mitani Y, et al: Loss of heterozygosity and histone hypoacetylation of the PINX1 gene are associated with reduced expression in gastric carcinoma. Oncogene 24: 157-164, 2005.
16. Ma Y, Wu L, Liu C, et al: The correlation of genetic instability of PINX1 gene to clinico-pathological features of gastric cancer in the Chinese population. J Cancer Res Clin Oncol 135: 431-437, 2009.
17. Liao C, Zhao MJ, Zhao J, et al: Over-expression of LPTS-L in hepatocellular carcinoma cell line SMMC-7721 induces crisis. World J Gastroenterol 8: 1050-1052, 2002.
18. Liao C, Zhao M, Song H, et al: Identification of the gene for a novel liver-related putative tumor suppressor at a high-frequency loss of heterozygosity region of chromosome 8p23 in human hepatocellular carcinoma. Hepatology 32: 721-727, 2000.
19. Sun J, Huang H, Zhu Y, et al: The expression of telomeric proteins and their probable regulation of telomerase during the differentiation of all-trans-retinoic acid-responsive and -resistant acute promyelocytic leukemia cells. Int J Hematol 82: 215-223, 2005.
20. Sun J, Tan YM, Huang H, et al: Expression of telomerase inhibitor Pinx1 in leukemia cells and its correlation with telomerase activity. Chinese J Pathophysiology 22: 1725-1728, 2006.
21. Hawkins GA, Chang BL, Zheng SL, et al: Mutational analysis of PINX1 in hereditary prostate cancer. Prostate 60: 298-302, 2004.
22. Akiyama Y, Maesawa C, Wada K, et al: Human PinX1, a potent telomerase inhibitor, is not involved in human gastrointestinal tract carcinoma. Oncol Rep 11: 871-874, 2004.
23. Chang Q, Pang JC, Li J, et al: Molecular analysis of PinX1 in medulloblastomas. Int J Cancer 109: 309-314, 2004.
24. Yuan K, Li N, Jiang K, et al: PinX1 is a novel microtubule-binding protein essential for accurate chromosome segregation. J Biol Chem 284: 23072-23082, 2009.
25. Hao J, Zhu L, Zhao S, et al: PTEN ameliorates high glucose-induced lipid deposits through regulating SREBP-1/FASN/ACC pathway in renal proximal tubular cells. Exp Cell Res 317: 1629-1639, 2011.
26. Feng X, Hao J, Liu Q, et al: HMGB1 mediates IFN-γ-induced cell proliferation in MMC cells through regulation of cyclin D1/CDK4/p16 pathway. J Cell Biochem 113: 2009-2019, 2012.
27. Wentzensen IM, Mirabello L, Pfeiffer RM and Savage SA: The association of telomere length and cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 20: 1238-1250, 2011.
28. Klingelhutz AJ: The roles of telomeres and telomerase in cellular immortalization and the development of cancer. Anticancer Res 19: 4823-4830, 1999.
29. Wang XW, Xiao J, Zhao S, et al: Expression of telomerase subunits and its relationship with telomerase activity in nasopharyngeal carcinoma. Zhonghua Yi Xue Za Zhi 81: 553-556, 2001 (In Chinese).
30. Liu H, Liu S, Wang H, et al: Genomic amplification of the human telomerase gene (hTERC) associated with human papillomavirus is related to the progression of uterine cervical dysplasia to invasive cancer. Diagnostic Pathol 7: 147, 2012.
31. Shen CX, Wen Z, Qian YH, et al: Targeted gene therapy of nasopharyngeal cancer in vitro and in vivo by enhanced thymidine kinase expression driven by human TERT promoter and CMV enhancer. J Exp Clin Cancer Res 29: 94, 2010.
32. Lai XF, Shen CX, Wen Z, et al: PinX1 regulation of telomerase activity and apoptosis in nasopharyngeal carcinoma cells. J Exp Clin Cancer Res 31: 12, 2012.
33. Zhang B, Bai YX, Ma HH, et al: Silencing PinX1 compromises telomere length maintenance as well as tumorigenicity in telomerase-positive human cancer cells. Cancer Res 69: 75-83, 2009.
34. Wang HB, Wang XW, Zhou G, et al: PinX1 inhibits telomerase activity in gastric cancer cells through Mad1/c-Myc pathway. J Gastrointest Surg 14: 1227-1234, 2010.
35. Zhou XZ and Lu KP: The Pin2/TRF1-interacting protein PinX1 is a potent telomerase inhibitor. Cell 107: 347-359, 2001.
36. Banik SS and Counter CM: Characterization of interactions between PinX1 and human telomerase subunits hTERT and hTR. J Biol Chem 279: 51745-51748, 2004.